8-K ·Filed Jul 6, 2026
8-K context-dependent: Items 5.02
Actionable Insight • Neutral
Routine board appointment with no immediate trading implications. Monitor for any future committee assignments or strategic shifts, but no action warranted.
Final — all horizons settled through T+60d ⚠ clustered
ABCL ▲ +88.31% at T+60d
NEUTRAL call ✓ call won +88.31% · α vs SPY +86.40% · entry $7.87 → $14.82
T+1d
-2.29%
call -2.29% · α -1.81%
$7.69
settled 3mo ago
T+5d
-13.60%
call -13.60% · α -14.08%
$6.80
settled 3mo ago
T+20d
-27.45%
call -27.45% · α -26.88%
$5.71
settled 2mo ago
T+60d
+88.31%
call +88.31% · α +86.40%
$14.82
settled 3d ago
Price Chart
Loading chart...
Executive Summary
AbCellera appointed Dr. Lynn Seely, an experienced biopharmaceutical executive, as an independent Class III director effective June 30, 2026. This is a routine board addition with no financial terms disclosed and no material impact on operations or strategy.
Key Facts
- Dr. Lynn Seely appointed as Class III director on June 30, 2026
- Board determined she is independent under Nasdaq rules
- Not appointed to any board committees
- Will participate in standard Non-Employee Director Compensation Policy
- No material interest in any related-party transactions
Financial Impact
No financial impact; standard director compensation only
Risk Factors
- No material risks identified from this filing
Market Snapshot
Exchange
Nasdaq
Sector
Pharmaceutical Preparations
Analyst Consensus
87% bullish (15 analysts)
Investment Themes
Biotech & Drug Discovery
Documents Analyzed
This report is based on 5 SEC documents filed with EDGAR.
| Document | Accession Number |
|---|---|
| 8-K Filing (Primary) | 0001703057-26-000037 |
| Document: a2026-07x06abcelleraappo.htm | 0001703057-26-000037 |
| Document: 0001703057-26-000037-index-headers.html | 0001703057-26-000037 |
| Document: 0001703057-26-000037-index.html | 0001703057-26-000037 |
| Document: 0001703057-26-000037.txt | 0001703057-26-000037 |
12 reports for ABCL
88% Hit rate best @ T+20▲ +127.09%
Filters
Rows
| Type | Now | ||||
|---|---|---|---|---|---|
Aug 24, 2026 5w ago | Insider Cluster | $10.61 $12.65 | ▲ +19.23% | ▲ +17.91% | $13.74 (+29.50%) |
Aug 18, 2026 6w ago | Insider Cluster | $11.12 $11.67 | ▲ +4.95% | ▲ +6.69% | $13.74 (+23.56%) |
Aug 15, 2026 6w ago | Institutional Cluster | $11.20 $11.41 | ▼ −1.88% | ▼ −3.85% | $13.74 (−22.68%) |
Aug 11, 2026 7w ago | 424B5 | $10.36 $10.46 | ▼ −1.01% | ▼ −2.91% | $13.74 (−32.69%) |
Aug 10, 2026 7w ago | 8-K | $9.34 $11.44 | ▲ +22.48% | ▲ +23.40% | $13.74 (+47.11%) |
Jul 29, 2026 9w ago | 8-K | $5.39 $12.24 | ▲ +127.09% | ▲ +122.07% | $13.74 (+154.92%) |
Jul 6, 2026 12w ago | 3 | $7.69 $5.83 | ▼ −24.19% | ▼ −25.52% | $13.74 (+78.67%) |
Jul 6, 2026 12w ago | 8-K | $7.87 $5.71 | ▼ −27.45% | ▼ −26.88% | $13.74 (+74.59%) |
Jun 5, 2026 17w ago | 8-K | $5.62 $7.87 | ▲ +40.04% | ▲ +38.17% | $13.74 (+144.48%) |
May 11, 2026 20w ago | 8-K | $4.95 $5.09 | ▲ +2.83% | ▲ +4.56% | $13.74 (+177.58%) |
Showing 10 of 12
US Market Status
Market Closed — Opens Mon (37h 48m)
Subscribe to SecBot
Get Real-Time SEC Filing Intelligence
Comprehensive SEC filing analysis delivered the moment filings hit EDGAR. Sentiment scoring, impact analysis, and actionable insights for every material event.
Try SecBot Free Coming soon: SecBot Pro with alerts, watchlists, and API access